Bio-Connect
Insulin ELISA Human Ultrasensitive

Insulin ELISA Human Ultrasensitive

Research Use Only
10-1132-01
Mercodia
Product group Assays
Price on request
96 wells
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Mercodia
  • Product Name
    Ultrasensitive Human Insulin ELISA
  • Delivery Days Customer
    5
  • Applications
    ELISA
  • Assay Detection Range
    0.15 - 20 mU/L
  • Certification
    Research Use Only
  • Scientific Description
    A high quality enzyme immunoassay for specific quantification of human insulin in serum or plasma. The Mercodia insulin assays have little or no cross-reactivity to insulin analogs, rat or mouse insulin, which enables distinguishing endogenous human insulin, both in patients undergoing treatment with insulin analogs, and in rat or mouse models. The Mercodia Insulin ELISAs are the only ELISA assays to satisfy the total error requirements in the Insulin Standardization Program. Mercodia Diabetes Antigen Control (10-1134-01 (US only) or 10-1164-01) is designed to be used as a two-level control in the Ultrasensitive Insulin ELISA. • Calibrated against 1st International Reference Preparation 66/304 for human insulin • No cross-reactivity to C-peptide or Proinsulin des(31-32) or split (32-33) • Insignificant or no cross-reactivity to insulin analogs • CE/IVD labeled on select markets
  • UNSPSC
    41116133

References

  • Straniero, S. et al. Acute caloric restriction counteracts hepatic bile acid and cholesterol deficiency in morbid obesity. J. Intern. Med. 281, 507–517 (2017)
    Read more
  • Deere K, Sayers A, Viljakainen HT, et al. Distinct relationships of intramuscular and subcutaneous fat with cortical bone: findings from a cross-sectional study of young adult males and females. J Clin Endocrinol Metab. 2013;98(6):E1041-9.
    Read more
  • Sorelle JA, Kanak MA, Itoh T, Horton JM, Naziruddin B, Kane RR. Comparison of surface modification chemistries in mouse, porcine, and human islets. J Biomed Mater Res A. 2015;103(3):869-77.
    Read more
  • Monacelli F, Borghi R, Cammarata S, et al. Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters. J Alzheimers Dis. 2015;45(1):89-95.
    Read more